GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lionco Pharmaceutical Group Co Ltd (SHSE:603669) » Definitions » Investments And Advances

Lionco Pharmaceutical Group Co (SHSE:603669) Investments And Advances : ¥0.0 Mil (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Lionco Pharmaceutical Group Co Investments And Advances?

Lionco Pharmaceutical Group Co's Investments And Advances for the quarter that ended in Mar. 2025 was ¥0.0 Mil.


Lionco Pharmaceutical Group Co Investments And Advances Historical Data

The historical data trend for Lionco Pharmaceutical Group Co's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lionco Pharmaceutical Group Co Investments And Advances Chart

Lionco Pharmaceutical Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Lionco Pharmaceutical Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Lionco Pharmaceutical Group Co Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Lionco Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 20, National Highway 349, Naidong District, Shannan, CHN
Lionco Pharmaceutical Group Co Ltd is engaged in the research and development of medicines. The product portfolio includes - Alanyl glutamine for injection, fructose for injection, inverted sugar for injection, xylitol for injection, riboflavin sodium phosphate for injection, and water-soluble vitamin for injection.
Executives
Zhang Jun Ke Director
Wang Wen Nan Director
Tao Xiao Gang Director
Tao Ling Gang Director
Tao Ling Ping Director

Lionco Pharmaceutical Group Co Headlines

No Headlines